NCT01710618

Brief Summary

The purpose of the study is to elucidate the different proteins that may appear on the "injured" end of the sciatic nerve and compare it to the other end of the cut nerve, which is "uninjured". By comparing the "normal" versus "traumatized" ends of the cut sciatic nerve, the investigators hope to identify proteins that may be specifically related to pain. For instance, if the non-traumatized end of the nerve has none of Protein X but the traumatized end of the nerve has a lot of Protein X, then Protein X would be a protein that the investigators will want to study further and see if it plays any role in the sensation of pain. Other studies have shown that there are specific pain-related proteins and they may be increased or decreased after traumatic injury. If the investigators are able to identify specific proteins that are related to pain, then that may eventually lead to the development of medications that will block those proteins and decrease the sensation of pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 19, 2012

Completed
12.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

April 6, 2023

Status Verified

April 1, 2023

Enrollment Period

13.7 years

First QC Date

October 17, 2012

Last Update Submit

April 5, 2023

Conditions

Keywords

Protein Expression of Sciatic Nervetraumatized sciatic nerve

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Male or female Operation Iraqi Freedom (OIF)/(Operation New Dawn (OND) or Operation Enduring Freedom (OEF) veterans who meet eligibility criteria who require an amputation revision occurring during their initial hospital admission.

You may qualify if:

  • Males and females 18 years and older, capable of providing informed consent indicating awareness of the investigational nature of the study, in keeping with institutional policy
  • Written informed consent must be obtained from each subject prior to entering the study
  • Traumatic lower extremity (above knee or below knee) amputation that occurred as a result of exposure to improvised explosive device (IED) blast, gunshot, or vehicle rollover during combat in support of OIF/OND or OEF.
  • Scheduled final amputation revision to occur during the initial hospital admission at Walter Reed National Military Medical Center

You may not qualify if:

  • Inability to provide informed consent
  • Traumatic or surgical foot amputations
  • Amputation occurring at Walter Reed Army Medical Center or another continental United States (CONUS) hospital after failed limb salvage
  • Nerve specimen less than 5cm in length

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

sciatic nerve specimen will be obtained

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Chester c Buckenmaier

    Defense and Veterans Center for Integrative Pain Management

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2012

First Posted

October 19, 2012

Study Start

July 1, 2011

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

April 6, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations